Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2014.01.007
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Elsevier BV
Available in full text
October 1, 2014
Elsevier BV